204 related articles for article (PubMed ID: 33781961)
21. The dipeptidyl peptidase 4 inhibitor sitagliptin improves oxidative stress and ameliorates glomerular lesions in a rat model of type 1 diabetes.
Marques C; Gonçalves A; Pereira PMR; Almeida D; Martins B; Fontes-Ribeiro C; Reis F; Fernandes R
Life Sci; 2019 Oct; 234():116738. PubMed ID: 31398418
[TBL] [Abstract][Full Text] [Related]
22. Positive interplay between FFAR4/GPR120, DPP-IV inhibition and GLP-1 in beta cell proliferation and glucose homeostasis in obese high fat fed mice.
Owolabi AI; Corbett RC; Flatt PR; McKillop AM
Peptides; 2024 Jul; 177():171218. PubMed ID: 38621590
[TBL] [Abstract][Full Text] [Related]
23. Anagliptin, a dipeptidyl peptidase-4 inhibitor, decreases macrophage infiltration and suppresses atherosclerosis in aortic and coronary arteries in cholesterol-fed rabbits.
Hirano T; Yamashita S; Takahashi M; Hashimoto H; Mori Y; Goto M
Metabolism; 2016 Jun; 65(6):893-903. PubMed ID: 27173468
[TBL] [Abstract][Full Text] [Related]
24. CB-1R and GLP-1R gene expressions and oxidative stress in the liver of diabetic rats treated with sitagliptin.
Coskun ZM; Koyuturk M; Karabulut S; Bolkent S
Pharmacol Rep; 2017 Aug; 69(4):822-829. PubMed ID: 28599244
[TBL] [Abstract][Full Text] [Related]
25. Sitagliptin alleviated myocardial remodeling of the left ventricle and improved cardiac diastolic dysfunction in diabetic rats.
Liu YS; Huang ZW; Wang L; Liu XX; Wang YM; Zhang Y; Zhang M
J Pharmacol Sci; 2015 Mar; 127(3):260-74. PubMed ID: 25837922
[TBL] [Abstract][Full Text] [Related]
26. Vildagliptin, a DPP-4 Inhibitor, Attenuates Endothelial Dysfunction and Atherogenesis in Nondiabetic Apolipoprotein E-Deficient Mice.
Aini K; Fukuda D; Tanaka K; Higashikuni Y; Hirata Y; Yagi S; Kusunose K; Yamada H; Soeki T; Sata M
Int Heart J; 2019 Nov; 60(6):1421-1429. PubMed ID: 31735774
[TBL] [Abstract][Full Text] [Related]
27. Sitagliptin prevents inflammation and apoptotic cell death in the kidney of type 2 diabetic animals.
Marques C; Mega C; Gonçalves A; Rodrigues-Santos P; Teixeira-Lemos E; Teixeira F; Fontes-Ribeiro C; Reis F; Fernandes R
Mediators Inflamm; 2014; 2014():538737. PubMed ID: 24817793
[TBL] [Abstract][Full Text] [Related]
28. Glucagon-Like Peptide-1 Mediates the Protective Effect of the Dipeptidyl Peptidase IV Inhibitor on Renal Fibrosis via Reducing the Phenotypic Conversion of Renal Microvascular Cells in Monocrotaline-Treated Rats.
Xu J; Wang J; Cheng Y; Li X; He M; Zhu J; Han H; Wei G; Kong H; Xie W; Wang H; Zuo X
Biomed Res Int; 2018; 2018():1864107. PubMed ID: 29607314
[TBL] [Abstract][Full Text] [Related]
29. Increased dipeptidyl peptidase-4 accelerates diet-related vascular aging and atherosclerosis in ApoE-deficient mice under chronic stress.
Lei Y; Yang G; Hu L; Piao L; Inoue A; Jiang H; Sasaki T; Zhao G; Yisireyili M; Yu C; Xu W; Takeshita K; Okumura K; Kuzuya M; Cheng XW;
Int J Cardiol; 2017 Sep; 243():413-420. PubMed ID: 28549747
[TBL] [Abstract][Full Text] [Related]
30. Effect of sitagliptin on tubulointerstitial Wnt/β-catenin signalling in diabetic nephropathy.
Ren X; Zhu R; Liu G; Xue F; Wang Y; Xu J; Zhang W; Yu W; Li R
Nephrology (Carlton); 2019 Nov; 24(11):1189-1197. PubMed ID: 31412145
[TBL] [Abstract][Full Text] [Related]
31. Sitagliptin reduces inflammation, fibrosis and preserves diastolic function in a rat model of heart failure with preserved ejection fraction.
Esposito G; Cappetta D; Russo R; Rivellino A; Ciuffreda LP; Roviezzo F; Piegari E; Berrino L; Rossi F; De Angelis A; Urbanek K
Br J Pharmacol; 2017 Nov; 174(22):4070-4086. PubMed ID: 27922176
[TBL] [Abstract][Full Text] [Related]
32. Dipeptidyl peptidase IV regulates proliferation of preglomerular vascular smooth muscle and mesangial cells.
Jackson EK; Kochanek SJ; Gillespie DG
Hypertension; 2012 Sep; 60(3):757-64. PubMed ID: 22802229
[TBL] [Abstract][Full Text] [Related]
33. Sitagliptin and Roux-en-Y gastric bypass modulate insulin secretion via regulation of intra-islet PYY.
Guida C; McCulloch LJ; Godazgar M; Stephen SD; Baker C; Basco D; Dong J; Chen D; Clark A; Ramracheya RD
Diabetes Obes Metab; 2018 Mar; 20(3):571-581. PubMed ID: 28892258
[TBL] [Abstract][Full Text] [Related]
34. Dipeptidyl peptidase-4 inhibition by gemigliptin prevents abnormal vascular remodeling via NF-E2-related factor 2 activation.
Choi SH; Park S; Oh CJ; Leem J; Park KG; Lee IK
Vascul Pharmacol; 2015 Oct; 73():11-9. PubMed ID: 26187356
[TBL] [Abstract][Full Text] [Related]
35. Exenatide mitigated diet-induced vascular aging and atherosclerotic plaque growth in ApoE-deficient mice under chronic stress.
Yang G; Lei Y; Inoue A; Piao L; Hu L; Jiang H; Sasaki T; Wu H; Xu W; Yu C; Zhao G; Ogasawara S; Okumura K; Kuzuya M; Cheng XW
Atherosclerosis; 2017 Sep; 264():1-10. PubMed ID: 28734203
[TBL] [Abstract][Full Text] [Related]
36. Significance of vascular dipeptidyl peptidase-4 inhibition on vascular protection in Zucker diabetic fatty rats.
Takai S; Sakonjo H; Jin D
J Pharmacol Sci; 2014; 125(4):386-93. PubMed ID: 25030743
[TBL] [Abstract][Full Text] [Related]
37. Influence of Dipeptidyl Peptidase-IV Inhibitor Sitagliptin on Extracellular Signal-Regulated Kinases 1/2 Signaling in Rats with Diabetic Nephropathy.
Ren X; Liu G; Wang Y; Zhang W; Xue F; Li R; Yu W
Pharmacology; 2017; 100(1-2):1-13. PubMed ID: 28329747
[TBL] [Abstract][Full Text] [Related]
38. Glucagon-like peptide-1 response to whey protein is less diminished by dipeptidyl peptidase-4 in comparison with responses to dextrin, a lipid and casein in rats.
Shimizu Y; Hara H; Hira T
Br J Nutr; 2021 Feb; 125(4):398-407. PubMed ID: 32713353
[TBL] [Abstract][Full Text] [Related]
39. The dipeptidyl peptidase-4 inhibitor sitagliptin suppresses mouse colon tumorigenesis in type 2 diabetic mice.
Yorifuji N; Inoue T; Iguchi M; Fujiwara K; Kakimoto K; Nouda S; Okada T; Kawakami K; Abe Y; Takeuchi T; Higuchi K
Oncol Rep; 2016 Feb; 35(2):676-82. PubMed ID: 26573958
[TBL] [Abstract][Full Text] [Related]
40. Hindbrain DPP-IV inhibition improves glycemic control and promotes negative energy balance.
Mietlicki-Baase EG; McGrath LE; Koch-Laskowski K; Krawczyk J; Pham T; Lhamo R; Reiner DJ; Hayes MR
Physiol Behav; 2017 May; 173():9-14. PubMed ID: 28119159
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]